Management of Sleep Disordered Breathing in Patients with Heart Failure
- 267 Downloads
Purpose of Review
This paper reviews treatment options for sleep disordered breathing (SDB) in patients with heart failure. We sought to identify therapies for SDB with the best evidence for long-term use in patients with heart failure and to minimize uncertainties in clinical practice by examining frequently discussed questions: what is the role of continuous positive airway pressure (CPAP) in patients with heart failure? Is adaptive servo-ventilation (ASV) safe in patients with heart failure? To what extent is SDB a modifiable risk factor?
Consistent evidence has demonstrated that the development of SDB in patients with heart failure is a poor prognostic indicator and a risk factor for cardiovascular mortality. However, despite numerous available interventions for obstructive sleep apnea and central sleep apnea, it remains unclear what effect these therapies have on patients with heart failure. To date, all major randomized clinical trials have failed to demonstrate a survival benefit with SDB therapy and one major study investigating the use of adaptive servo-ventilation demonstrated harm.
Significant questions persist regarding the management of SDB in patients with heart failure. Until appropriately powered trials identify a treatment modality that increases cardiovascular survival in patients with SDB and heart failure, a patient’s heart failure management should remain the priority of medical care.
KeywordsHeart failure Treatment of sleep disordered breathing Obstructive sleep apnea Central sleep apnea ASV
Compliance with Ethical Standards
Conflict of Interest
Manjula Ananthram and Connor P. Oates declare no conflicts of interest. Stephen S. Gottlieb reports grants from Respicardia and grants from Resmed, outside the submitted work.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 1.• Arzt M, Oldernburg O, Graml A, Erdmann E, Teschler H, Wegscheider K, et al. Phenotyping of sleep-disordered breathing in patients with chronic heart failure with reduced ejection fraction—the SchlaHF registry. J Am Heart Assoc. 2017;6:e005899. Important description of the epidemiology of sleep apnea in heart failure patients. CrossRefPubMedPubMedCentralGoogle Scholar
- 11.• Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, Drazner MH, Filippatos GS, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the Management of Heart Failure. J Card Fail 2017; 23 (8): 628–651. Important consensus document recommending therapy for heart failure. Google Scholar
- 18.• Peker Y, Glantz H, Eulenburg C, Wegscheider K, Herlitz J, Thunström E. Effect of positive airway pressure on cardiovascular outcomes in coronary artery disease patients with nonsleepy obstructive sleep apnea; the RICCADSA randomized controlled trial. Am J Respir Crit Care Med. 2016;194:613–20. Further evidence that treatment of sleep apnea may not improve cardiovascular events in patients without heart failure. Google Scholar
- 23.• Khayat R, Abraham W, Patt B, Brinkman V, Wannemacher J, Porter K, et al. Central sleep apnea is a predictor of cardiac readmission in hospitalized patients with systolic heart failure. J Card Fail. 2012;18:534–40. Supports the concept that CSA reflects severe heart failure. CrossRefPubMedPubMedCentralGoogle Scholar
- 37.Toyama T, Seki R, Kasama S, Isobe N, Sakurai S, Adachi H, et al. Effectiveness of nocturnal home oxygen therapy to improve exercise capacity, cardiac function and cardiac sympathetic nerve activity in patients with chronic heart failure and central sleep apnea. Circ J. 2009;73:299–304.CrossRefPubMedGoogle Scholar
- 38.• Sepehrvand N, Ezekowitz JA. Oxygen therapy in patients with acute heart failure. J Am Coll Cardiol Heart Fail. 2016;4:783–90. Raises important questions about oxygen therapy in patients with SDB. Google Scholar
- 46.Arzt M, Floras JS, Logan AG, Kimoff RJ, Series F, Morrison D, et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian continuous positive airway pressure for patients with central sleep apnea and heart failure trial (CANPAP). Circulation. 2007;115:3173–80.CrossRefPubMedGoogle Scholar
- 48.Morgenthaler TI, Kuzniar TJ, Wolfe LF, Willes L, McLain WC 3rd, Goldberg R. The complex sleep apnea resolution study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy. Sleep. 2014;37(5):927–34.CrossRefPubMedPubMedCentralGoogle Scholar
- 49.• Cowie MR, Woehrle H, Wegscheider K, Angermann C, d'Ortho MP, Erdmann E, et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. N Engl J Med. 2015;373:1095–105. Important demonstration that although ASV improves sleep apnea, it can increase mortality under certain circumstances. CrossRefPubMedPubMedCentralGoogle Scholar
- 50.Kasai T, Usui Y, Yoshioka T, Yanagisawa N, Takata Y, Narui K, et al. Effect of flow-triggered adaptive servo-ventilation compared with continuous positive airway pressure in patients with chronic heart failure with coexisting obstructive sleep apnea and Cheyne-Stokes respiration. Circ Heart Fail. 2010;3:140–8.CrossRefPubMedGoogle Scholar
- 51.• Eulenburg C, Wegscheider K, Woehrle H, Angermann C, d'Ortho MP, Erdmann E, et al. Mechanisms underlying increased mortality risk in patients with heart failure and reduced ejection fraction randomly assigned to adaptive servoventilation in the SERVE-HF study: results of a secondary multistate modelling analysis. Lancet Respir Med. 2016;4(11):873–81. Helping to shed light on possible mechanisms of the results of SERVE-HF. CrossRefPubMedGoogle Scholar
- 54.• Lyons OD, Floras JS, Logan AG, Beanlands R, Cantolla JD, Fitzpatrick M, et al. Design of the effect of adaptive servo-ventilation on survival and cardiovascular hospital admissions in patients with heart failure and sleep apnoea: the ADVENT-HF trial. Eur J Heart Fail. 2017;19(4):579–87. A study which should help us to determine the true effects of ASV in heart failure patients. CrossRefPubMedGoogle Scholar
- 55.• O’Connor CM, Whellan DJ, Fiuzat M, Punjabi NM, Tasissa G, Anstrom KJ, et al. Cardiovascular outcomes with minute ventilation—targeted adaptive servo-ventilation therapy in heart failure. J Am Coll Cardiol. 2017;69(12):1577–158. Raises questions about the impact of ASV in HFpEf. CrossRefPubMedGoogle Scholar
- 57.Yoshihisa A, Suzuki S, Yamaki T, Sugimoto K, Kunii H, Nakazato K, et al. Impact of adaptive servo-ventilation on cardiovascular function and prognosis in heart failure patients with preserved left ventricular ejection fraction and sleep-disordered breathing. Eur J Heart Fail. 2013;15(5):543–50.CrossRefPubMedGoogle Scholar
- 58.Heider K, Arzt M, Lerzer C, Kolb L, Pfeifer M, Maier LS, Gfüllner F, Malfertheiner MV. Adaptive servo-ventilation and sleep quality in treatment emergent central sleep apnea and central sleep apnea in patients with heart disease and preserved ejection fraction. Clin Res Cardiol. 2018. https://doi.org/10.1007/s00392-018-1203-9.
- 63.• Costanzo MR, Ponikowski P, Javaheri S, Augostini R, Goldberg L, Holcomb R, et al. Transvenous neurostimulation for central sleep apnoea: a randomized controlled trial. Lancet. 2016;388:974–82. Demonstration that central sleep apnea can be successfully treated with phrenic pacing. CrossRefPubMedGoogle Scholar
- 64.• Iturriaga R, Del Rio R, Idiaquez J, Somers VK. Carotid body chemoreceptor, sympathetic neural activation and cardiometabolic disease. Biol Res. 2016;49:13. Interesting concept that CSA can be treated by addressing carotid body chemoreceptors. Google Scholar
- 65.Del Rio R, Andrade DC, Marcus NJ, Schultz HD. Selective carotid body ablation in experimental heart failure: a new therapeutic tool to improve cardiorespiratory control. Exp Physiol. 2015;100(2):136–42. Excellent review of mechanisms by which the carotid body might impact respiration. CrossRefPubMedPubMedCentralGoogle Scholar
- 66.Marcus NJ, Del Rio R, Schultz EP, Xia XH, Schultz HD. Carotid body denervation improves autonomic and cardiac function and attenuates disordered breathing in congestive heart failure. J Physiol. 2014;592(2):391–408.Google Scholar
- 67.Niewinski P. Carotid body modulation in systolic heart failure from the clinical perspective. J Physiol. 2017;595(1):53–61.Google Scholar
- 68.• Pinna GD, Robbi E, La Rovere MT, Taurino AE, Bruschi C, Guazzotti G, et al. Differential impact of body position on the severity of disordered breathing in heart failure patients with obstructive vs. central sleep apnoea. Eur J Heart Fail. 2015;17:1302–9. In both CSA and OSA, AHI markedly decreased from the supine to the lateral position. Google Scholar